Tepnel is a GMP quality assured analytical testing facility, with over 30 years of expertise and knowledge in a wide range of cost-effective services for the whole drug development process.
Our team were recently approached to develop two new methods for peptide drug products, what can sometimes be a challenging task. However, utilising our extensive experience and high-quality testing technology, we were able to provide a series of benefits to our clients.
Now with ICH Q14, there will be a requirement to document the method development approach to ensure a method is fit for the life cycle of the product by highlighting the critical method parameters that require control (CCPs). This is best achieved by using a software package such as the Matrix Fusion AQbD package that we use here at Tepnel.
Choosing Tepnel for method development meant that we could offer the following advantages:
- Increase efficiency by reducing run time by over 50%
- Increase separation, with a 5-fold increase in resolution
- 10-fold increase in sensitivity for detecting impurity leaks
- Time and cost savings
Click on the video below to listen to our Business Development Manager, Stewart Neithercut discussing the recent case studies and how we supported our client with a service tailored to their specific needs.
You may also be interested in:
API and Finished Product
Large Molecule Formulations
Potency, Purity, Stability indicating
